August 1994
Volume 35, Issue 9
Free
Articles  |   August 1994
Membrane-bound carbonic anhydrase in human retinal pigment epithelium.
Author Affiliations
  • T J Wolfensberger
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • I Mahieu
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • J Jarvis-Evans
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • M Boulton
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • N D Carter
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • A Nógrádi
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • E Hollande
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
  • A C Bird
    Department of Clinical Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.
Investigative Ophthalmology & Visual Science August 1994, Vol.35, 3401-3407. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T J Wolfensberger, I Mahieu, J Jarvis-Evans, M Boulton, N D Carter, A Nógrádi, E Hollande, A C Bird; Membrane-bound carbonic anhydrase in human retinal pigment epithelium.. Invest. Ophthalmol. Vis. Sci. 1994;35(9):3401-3407.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: Inhibition of carbonic anhydrase (CA) by acetazolamide causes a decrease in the standing potential of the retinal pigment epithelium (RPE) and an increase in the rate of subretinal fluid absorption, and it may improve cystoid macular edema. These effects are thought to be mediated by the RPE. Given the solubility coefficient of acetazolamide, the drug is most likely to act by direct inhibition of membrane-bound CA (CA IV). To identify a substrate for acetazolamide in the RPE, the distribution of CA activity and the isoform of CA in the RPE membrane were investigated. METHODS: Carbonic anhydrase activity was determined by Hansson's technique in fresh human eyes from donors of both sexes and different ages. The presence of the membrane-bound isoform CA IV was investigated immunohistochemically at the light and electron microscopic level, as well as by Western blotting in fresh RPE, and in adult and fetal RPE cultures. RESULTS: Hansson's histochemical method demonstrated CA activity on the apical and basolateral cell membrane of the RPE. Using the gamma-globulin fraction of a polyclonal antibody against pure CA IV, immunocytochemistry showed labeling for CA IV on the apical RPE membrane or morphologically polarized human adult and fetal RPE cultures. Gel electrophoresis and Western blotting demonstrated a major immunoreactive band at 55 kDa in homogenates, which was consistently reduced to approximately 35 kDa by incorporation of 0.1% Triton X-100 detergent. CONCLUSIONS: These results suggest that the clinical effects of carbonic anhydrase inhibitors on RPE function may be mediated via membrane-bound carbonic anhydrase activity in RPE and that CA IV is responsible for activity on the apical surface.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×